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Background: Multiple epiphyseal dysplasia is a common skeletal dysplasia characterized by mild short stature,
early-onset osteoarthritis mainly involving the hip and knee joints, and abnormally small and/or irregular epiphyses.
Multiple epiphyseal dysplasia is clinically and genetically heterogeneous and six genes are associated with the
phenotype of multiple epiphyseal dysplasia.
Case presentation: A 12-year-old Korean boy presented with intermittent knee pain. His height was 144.6 cm
(20th percentile) and family history was notable for early-onset osteoarthritis in his father. The proband’s x-rays
revealed epiphyseal changes characteristic of multiple epiphyseal dysplasia associated with a collagen IX defect,
with manifestations primarily restricted to the knees. Mutational analysis identified a novel c.104G > A substitution in
exon 2 of COL9A3, resulting in p.Gly35Asp in the proband and his father. In silico analyses predicted the p.Gly35Asp
amino acid change to be detelerious, and molecular dynamics simulation demonstrated a major structural change
in the heterotrimeric collagen IX.
Conclusion: So far, three COL9A3 mutations, have been reported. These three mutations are located at the splice
donor or acceptor site of COL9A3 and cause skipping of exon 3, resulting in the deletion of 12 aminoacids in the
COL3 domain of COL9A3. In contrast, the novel missense mutation identified in this two-generation family with
multiple epiphyseal dysplasia is a missense mutation affecting the Gly residue of the Pro-Pro-Gly repeat sequence
in the COL3 domain of collage IX, with accompanying major structural change of the collagen peptide.
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Multiple epiphyseal dysplasia (MED) is clinically and
genetically heterogeneous group of skeletal dysplasias
characterized by early-onset osteoarthritis, a waddling
gait, restriction of joint mobility, pain and stiffness in
the weight-bearing joints and sometimes short stature.
Mutations in six different genes cause MED. Mutations
in genes encoding cartilage oligomeric matrix protein
(COMP), matrilin-3 (MATN3), and the alpha 1–3 chains
of type IX collagen (COL9A1, COL9A2, COL9A3) result in
autosomal dominant MED [1], and a specific mutation in
the diastrophic dysplasia sulfate transporter (DTDST) is* Correspondence: microkim@catholic.ac.kr
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unless otherwise stated.associated with an autosomal recessive form of MED [2].
The frequencies of mutations in these genes among MED
patients have yet to be determined. Previous studies in
European MED patients have shown frequencies of
7–35% for COMP, 14% for DTDST, 5–10% for MATN3,
and 5–15% for the type IX collagen genes [3,4]. The fre-
quencies of causative genes showed racial differences. A
comprehensive screening in a Japanese population indi-
cated that frequencies differ in East Asian patients, with
reported frequencies of 23% in MATN3, 20% in COMP,
6% in COL9A2, and none in DTDST [5]. In Korean pa-
tients, MATN3 mutations were found in 55% of patients,
followed by COMP mutations in 41%, and COL9A2 and
DTDST mutations in one patients (2%), respectively [6].
Genotype-phenotype correlations of MED has been de-
scribed and MED resulting from collagen IX defects
(COL9-MED) result in more severe involvement of the
knees with relative sparing of the hips.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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notypes consistent with COL9-MED, that were caused by
a novel missense mutation in COL9A3.
Case presentation
Patient’s characteristics
The proband was a 12-year-old Korean boy born to non-
consanguineous parents. He had been treated for partial
seizure disorder for 2 years. He was referred to the pediatric
orthopedic clinic for the evaluation of intermittent knee
pain that had occurred for a few months. His height was
144.6 cm (20th percentile) and bodyweight was 41 kg
(60th percentile). The height of his father and mother was
170 cm and 160 cm, respectively. His father also suffered
from intermittent mild knee joint pain. The proband and
his father did not show muscle weakness and pain
suggesting myopathy. There was no Gower sign and
Trendelenberg sign on physical examination. The level of
creatine kinase and lactate were normal. Informed consent
was obtained from the parents of the child.
Orthopedic and radiologic evaluations
Clinically, the lower extremity of the proband showed
mild genu valgum deformity. The knee joints displayed full
range of motion. The distal femoral and proximal tib-
ial epiphyses were affected most, and the distal tibia
and distal radius epiphyses were affected less severely.
There was no irregularity on the femoral head epiphysis.
Distal femoral and proximal tibial epiphyses showed
loss of height, joint surface irregularities and fragmen-
tation (Figure 1A and B). The epiphysis of the distal tibiaFigure 1 Radiographs of proband at the age of 12 years. Anteroposter
surface irregularity of distal femoral and proximal tibial epiphysis (A, B). An
and fragmentation (C, D). The tarsal navicular and cuneiform bone showed
shaped and the epiphyses of the distal ulnae were relatively small and the
proximal femur were spared (G).showed lateral shortening and fragmentation (Figure 1C
and D). There was no abnormality of the distal fibular
epiphysis nor the talar dome. The tarsal navicular and cu-
neiform bone showed irregular ossification (Figure 1E).
The epiphysis of distal radius was wedged shape and the
epiphyses of the distal ulnae were relatively small. The car-
pal bone shows dysplasia and flattening (Figure 1F). The
spine and the proximal femoral epiphyses appeared nor-
mal (Figure 1G). X-rays of the proband’s father revealed
osteoarthritis of Kellgren-Lawrence grade I particularly on
the medial side (Figure 2A). However, the proximal fem-
oral epiphyses were spared (Figure 2B). Other members of
the family were not affected.
Genetic analyses
PCR from genomic DNA followed by direct sequencing
was performed following parental informed consent.
Genomic DNA was isolated from peripheral blood leu-
kocytes. Direct DNA sequencing of the COMP, MANT3,
COL9A1, COL9A2, and COL9A3 genes was performed.
All exons were amplified using the primers previously
described (Table 1). PCR amplicons were bidirectionally
sequenced with the Big Dye terminator v3.1 cycle se-
quencing kit (Applied Biosystems, Foster City, CA) using
an ABI PRISM 3130 Genetic Analyzer (Applied Biosys-
tems). COMP, MATN3, COL9A1 and COL9A2 revealed
no mutations. A novel missense mutation c.104G>A in
exon2 of COL9A3, which resulted in p.Gly35Asp, was
identified. RefSeq ID: NM_001853.3 reference sequence
was used for cDNA nucleotide numbering. This mutation
was predicted to be not tolerated by SIFT and probablyior view of knee joint showed shortening, fragmentation, and joint
teroposterior view of distal tibial epiphysis showed a lateral wedging
irregular ossification (E). The epiphysis of distal radius was wedge
carpal bone shows dysplasia and flattening (F). The epiphyses of
Figure 2 Radiographs of the proband’s father at the age of 41 years. Anteroposterior view of knee joints revealed early osteoarthritis with
findings including of medial joint space narrowing and joint surface irregularity (A). The capital femoral epiphysis of the proband’s father has no
evidence of dysplasia (B).
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ary analysis showed that the glycine residue at codon 35 is
a highly conserved amino acid during evolution. And
the same mutation was observed in the proband’s symp-
tomatic father. We performed Sanger sequencing of 100
healthy controls and none harbored a c.104G>A mutation
in exon 2 of COL9A3.
Molecular Dynamics (MD) simulation of wild type and
mutant model structure of trimer collagen IX
Molecular mechanics potential energy minimization and
MD simulations were carried out using the program pack-
age AMBER 11 [9]. FF99 force field in AMBER package
was used in all MD simulations including hetero atoms.
Topology file GAFF force field in AMBER package was
used. The generalized Born solvation model was used in-
stead of explicit water [10]. The temperature was kept
constant by using Langevin dynamics with a collision fre-
quency of 5.0 ps−1 [11]. The minimized system was heated
from 0 K to 325 K for 50 ps in a total of 7 stages. By heat-
ing gradually in stages, the possible crashes will be re-
duced by allowing it to equilibrate at each temperature.
The heated systems were then subjected to molecular dy-
namics simulations for 1 ns each at 325 K in a total of 10
stages. In all simulations, the temperature was kept con-
stant at 325 K. The simulations were performed using the
PMEMD module with GPU system which utilizes the par-
ticle mesh Ewald method [12]. SHAKE algorithm was
used to constrain bond lengths involving hydrogen [13].
The mutation of p.Gly35Asp in type IX collagen alpha 3
has a Pro-Pro-Gly consecutive residue pattern. The colla-
gen model structure was generated with a template of 2v53
PDB (protein database bank). After the MD simulation, the
wild type and mutant collagen structures were visually
inspected. The wild type structure formed hydrogen bonds
with its neighboring strand while the mutant was aggre-
gated by themselves (Figure 3A to D). In addition, the dis-
tances between the mutation site (C-alpha) of the wild
type and the mutant collagen are almost twice (Figure 3Eand F). The calculated energy state of the mutant is much
lower, causing a self aggregation (Figure 3G). Considering
the major structural change caused by the collagen mu-
tant, a malfunction of the type IX collagen is expected.
Conclusions
The clinical and radiographic phenotypes of MED vary
heterogenously according to the genetic mutation. COMP
and MATN3 mutations show marked abnormalities in hip
and knee joints. Patients with the COMP mutation have
characteristics of marked alterations of hip joints leading
to severe osteoarthritis in early childhood [14]. The
MATN3 mutation has dysplastic epiphysis of the proximal
and distal femur [15]. Clinical features of autosomal reces-
sive MED associated with DTDST mutations include scoli-
osis and abnormal findings such as clubfoot, cleft palate,
cystic ear swelling, and clinodactyly are present at birth in
approximately 50% of individuals [16]. COL9-MED is gen-
erally the mildest form of MED and is characterized by
joint pain in the hips and/or knees and stiffness presenting
in the first decade of life, while radiographic abnormalities
are primarily restricted to the knees with relative sparing
of the hips [4]. Epiphyseal flattening and irregularity of
affected joint are evident. MED-related myopathy has
been reported in some families with COL9A3, COMP, and
COL9A2 mutations [17,18].
We presently describe an autosomal dominant MED
family with novel COL9A3 mutation. The proband and
his father presented with mild knee joint pain. The height
of the proband was in the 20th percentile but his father’s
height was average for Korean males. Radiographs of the
proband showed epiphyseal changes of MED. The knee
joints were most severely affected but other joints revealed
minor involvement including ankle, foot, and wrist. Spar-
ing of hip joints, no history of clubfoot or other deform-
ities at birth, and the pattern of inheritance distinguished
their conditions from the other MED caused by COMP,
MATN3, and DTDST mutations. Therefore, we analyzed
the genes associated with collagen type IX on the bases of
Table 1 PCR primer sequences for COL9A1, COL9A2,
COL9A3, COMP, and MATN3
Primer sequences
COL9A1 gene Tm (°C) Product
size (bp)
Exon 8-10 F - CCGATGTGCTCCACTAACCT 56 824
R - GGCCAAGTTTAGAGCCACAG
COL9A2 gene
Exon 2 F - CAGCTTCCTGCACTGTCTGA 56 241
R - GACGAGGGGCACTACATCTC
Exon 3-4 F - TGAGCCGTAGTGTGCTGTCT 56 278
R - CTGGAGGTCAATTGGCAGAG
COL9A3 gene
Exon 2 F - TTTGGGTCTCACCGAGGA 56 293
R - GCCTGGTTTTCTCTCCATCA
Exon 3 F - CTTGAGGGACCCCTGATTTT 56 152
R - TGTTCTGAGTTCCCCCTTTC
Exon 4 F - GCATTTTGCTTCATTGCTGA 56 222
R - AATTAGGGCCGGACTCCTC
COMP gene
Exon 8-9 F - TTGAGGCGGGGTTGGGTG 64 413
R - ACCGTGCCGAGCCGTAGAT
Exon 10 F - AGGAGTGTGACCTTTGCCTTCT 64 334
R - CTAGTCCAGCTTACCCCATCC
Exon 11-12 F - GAAGTCATTCTGGCCTGGTC 64 518
R - AGCGTTTTGTCAAAGGCTACC
Exon 13 F - CGGGTAGCCTTTGACAAAACG 62 331
R - GCCCGCCCACCGTAGAC
Exon 14-15 F - GGCGGGCCCTGACTTTAG 64 546
R - ATAACCCCGCCCCTCTGT
Exon 16 F - GTTCTGGGTGCCAGGTTC 64 335
R - AAGGGTTTTACGGAGGGTCAT
Exon 17 F - TGCTCCCAACTGTCTCTCCA 64 312
R - ACCTGGGCCTGTGTGTCC
Exon 18-19 F - TCTGAGAGGGAAGGGTCTGG 64 443
R - CCCTTCTCACTTCCCCCTCA
MATN3 gene
Exon 3 F - AAAGGAGCCCAGAGAGCAAT 59 290
R - CAGTCCAAAACCTGGAGCAT
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the COL9A3 mutation detected in the proband and his
father is a missense mutation. Previously reported COL9A3
mutations were splice site acceptor or donor mutations
in intron 2 or 3, that invariably resulted in skipping
of exon 3 of COL9A3 [17,19] with deletion of 12 amino
acids in the COL3 domain of COL9A3. The c.104G> Asubstitution in exon 2 of COL9A3, resulting in p.Gly35Asp,
affects the COL3 domain of COL9A3, and results in
a substitution of Gly to Asp in the third position of
“Pro-Pro-Gly” consecutive sequence. The COL3 domain
is consistently affected in COL9A2 and COL9A3 muta-
tions associated with MED, thus emphasizing the role of
the COL3 domain in the pathogenesis of MED. Although,
the novel mutation does not result in a splicing defect of
the COL3 domain, it affects an important amino acid in a
conserved “Pro-Pro-Gly” repeat sequence of the highly
conserved COL3 domain.
Another point of interest is that the proband had
been treated for seizure disorder. A study characteriz-
ing a microdeletion of 20q13.33, a cytogenetic locus
in which COL9A3 is located, demonstrated that this
abnormality is associated with several clinical features in-
cluding mental retardation, developmental delay, speech
and language deficits, behavior problems and seizures.
In the study, two of six patients had deletions that encom-
passed COL9A3 and one had seizure disorder, but they
lacked in clinical features reminiscent of MED. The asso-
ciation between seizure and COL9A3 is not clear, but
the possibility should be considered. In addition, the
authors remarked that the suggested deletion of COL9A3
did not cause the MED symptom [20]. However, we
have a reservation with this opinion, because symptoms of
MED caused by COL9A3 mutations are mild and the
patients with microdeletion at 20q13.33 had combined
abnormalities in morphology and psychomotor and
behavioral development. It should be defined after
careful clinical and radiographic assessment.
Type IX collagen is the structural component of hya-
line cartilage and vitreous of the eye, and has been ob-
served in various tissues including the notochord, inner
ear, heart, brain, and skin in mice [21]. Collagen IX is a
hetero-trimeric molecule that consists of three α chains,
α1(IX), α2(IX), and α3(IX)) in a 1:1:1 ratio. And the
sizes of the domains and amino acid sequences of the
α1(IX), α2(IX), and α3(IX) chains are highly conserved.
Also the reported mutations in COL9A2 and COL9A3
show a remarkable consistency in affecting the COL3 do-
main [22], and clearly indicates that the COL3 domain is a
functionally important component of type IX collagen
in vivo. MD simulation of heterotrimer collagen IX re-
vealed that the wild type structure formed hydrogen
bonds with its neighboring strand, while the mutant
showed self-aggregation. In addition, the distances be-
tween the mutation site (C-alpha) of wild type and mu-
tant collagen are almost twice and the calculated energy
state of the mutant is much lower, causing a self-
aggregation. Our results reveal that the substitution of Gly
to Asp produces a large local disruption to the COL3 do-
main of COL9A3, enough to lead to a malfunction of the
type IX collagen.
Figure 3 MD simulation of wild type and mutant model structure of trimer collagen. Wild type model structure (A), twisted form of
the mutant (B), collagen-collagen interaction by a hydrogen bonding in wild type (C), the substitution of glycine to aspartic acid causing
an interaction with the self strand (D), C-alpha distance between residues in wild type and mutant trimer (E and F), respectively, and energy
plot of wild type and mutant collagen by Amber-GPU (G).
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http://www.biomedcentral.com/1471-2474/15/371Lastly, the phenotypic difference within family mem-
bers was also observed but neither of the family mem-
bers showed neuromuscular manifestations, a feature
that has been associated in a previous MED patient with
COL9A3 mutation [17]. It remains to be determined
whether both inter- and intra-familial phenotypic diver-
sity are common in type IX collagen mutations. As well,
the relationship between MED and other neuromuscular
manifestations must be clarified.
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